| Liver sinusoidal endothelial cells: Physiology and role in liver diseases J Poisson, S Lemoinne, C Boulanger, F Durand, R Moreau, D Valla, ... Journal of hepatology 66 (1), 212-227, 2017 | 924 | 2017 |
| A placebo-controlled trial of bezafibrate in primary biliary cholangitis C Corpechot, O Chazouillères, A Rousseau, A Le Gruyer, F Habersetzer, ... New England Journal of Medicine 378 (23), 2171-2181, 2018 | 500 | 2018 |
| Mottling score predicts survival in septic shock H Ait-Oufella, S Lemoinne, PY Boelle, A Galbois, JL Baudel, J Lemant, ... Intensive care medicine 37, 801-807, 2011 | 328 | 2011 |
| Origins and functions of liver myofibroblasts S Lemoinne, A Cadoret, H El Mourabit, D Thabut, C Housset Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (7), 948-954, 2013 | 187 | 2013 |
| The emerging roles of microvesicles in liver diseases S Lemoinne, D Thabut, C Housset, R Moreau, D Valla, CM Boulanger, ... Nature reviews Gastroenterology & hepatology 11 (6), 350-361, 2014 | 186 | 2014 |
| Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis S Lemoinne, A Kemgang, KB Belkacem, M Straube, S Jegou, ... Gut 69 (1), 92-102, 2020 | 167 | 2020 |
| Radiologic course of primary sclerosing cholangitis: assessment by threedimensional magnetic resonance cholangiography and predictive features of progression A Ruiz, S Lemoinne, F Carrat, C Corpechot, O Chazouillères, L Arrivé Hepatology 59 (1), 242-250, 2014 | 144 | 2014 |
| Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles S Lemoinne, A Cadoret, PE Rautou, H El Mourabit, V Ratziu, C Corpechot, ... Hepatology 61 (3), 1041-1055, 2015 | 129 | 2015 |
| New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases S Lemoinne, SL Friedman Current Opinion in Pharmacology 49, 60-70, 2019 | 61 | 2019 |
| Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French–Spanish experience S Lemoinne, A Pares, A Reig, KB Belkacem, ADK Fankem, F Gaouar, ... Clinics and research in hepatology and gastroenterology 42 (6), 521-528, 2018 | 58 | 2018 |
| Simple magnetic resonance scores associate with outcomes of patients with primary sclerosing cholangitis S Lemoinne, N Cazzagon, S El Mouhadi, PJ Trivedi, A Dohan, ... Clinical Gastroenterology and Hepatology 17 (13), 2785-2792. e3, 2019 | 54 | 2019 |
| Bioinformatic analysis of the protein/DNA interface B Schneider, J Černý, D Svozil, P Čech, JC Gelly, AG de Brevern Nucleic Acids Research 42 (5), 3381-3394, 2014 | 43 | 2014 |
| Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis L Lei, A Bruneau, H El Mourabit, J Guégan, T Folseraas, S Lemoinne, ... Hepatology 76 (5), 1360-1375, 2022 | 41 | 2022 |
| Portal myofibroblasts connect angiogenesis and fibrosis in liver S Lemoinne, D Thabut, C Housset Cell and tissue research 365, 583-589, 2016 | 35 | 2016 |
| The complementary value of magnetic resonance imaging and vibration-controlled transient elastography for risk stratification in primary sclerosing cholangitis N Cazzagon, S Lemoinne, S El Mouhadi, PJ Trivedi, F Gaouar, ... Official journal of the American College of Gastroenterology| ACG 114 (12 …, 2019 | 30 | 2019 |
| Role of Angiogenesis in the Pathogenesis of NAFLD L Lei, H EI Mourabit, C Housset, A Cadoret, S Lemoinne Journal of clinical medicine 10 (7), 1338, 2021 | 26 | 2021 |
| Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression E Loeuillard, H El Mourabit, L Lei, S Lemoinne, C Housset, A Cadoret Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (12 …, 2018 | 20 | 2018 |
| Culture model of rat portal myofibroblasts H El Mourabit, E Loeuillard, S Lemoinne, A Cadoret, C Housset Frontiers in Physiology 7, 120, 2016 | 17 | 2016 |
| Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis N Cazzagon, S El Mouhadi, Q Vanderbecq, C Ferreira, S Finnegan, ... JHEP Reports 4 (11), 100577, 2022 | 12 | 2022 |
| Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis AE Kremer, A Le Cleac’h, S Lemoinne, K Wolf, L De Chaisemartin, ... Gut 68 (10), 1902-1903, 2019 | 12 | 2019 |
